Julie M. Vose

TL;DR: ChlVPP with consolidative radiation therapy to sites of bulky disease is effective in advanced Hodgkin's disease and, compared with most other available regimens, is extremely well tolerated.

TL;DR: Autologous hematopoietic stem cell transplantation as a consolidation therapy after first complete or partial remission in high-risk aggressive NHL, mantle cell lymphoma, and peripheral T-cell lymphoma may improve progression-free survival.

TL;DR: It is demonstrated that bone marrow stromal cells alter the pattern of growth of lymphoma cells and may have an important role in the maintenance of occult lymphoma by inhibiting apoptosis.

TL;DR: A work group comprised of thought leaders from NCCN Member Institutions and other outside experts identified challenges across the REMS spectrum, including the areas of standardization, development and assessment of REMS programs, medication guides, provider knowledge and impact on prescribing, provider burden and compensation, and incorporation of REMs into clinical practice.

TL;DR: The recent developments in adoptive cellular immunotherapy with anti CD19 chimeric antigen receptor (CAR)-T cell are described, with emphasis on the complications of therapy and factors contributing to toxicities, efficacy, and resistance.